Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apatinib Combined”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06666166
What this trial is testing

SHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer

Who this might be right for
Advanced Gastric CarcinomaAdvanced Gastroesophageal Junction AdenocarcinomaAdvanced Colorectal Cancer
Yunpeng Liu 28
Large-scale testing (Phase 3)UnknownNCT05313282
What this trial is testing

A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab Versus Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification

Who this might be right for
C-staged Hepatocellular Carcinoma in BCLC Classification
Sun Yat-sen University 140
Early research (Phase 1)Study completedNCT02645864
What this trial is testing

Apatinib and Irinotecan Combination Treatment in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking University 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT06700421
What this trial is testing

Phase II Clinical Study of Adebrelimab Combined with Apatinib in the Treatment of Locally Advanced Non-small Cell Lung Cancer Patients with Radiation Pneumonitis

Who this might be right for
Unresectable Locally Advanced Non-small Cell Lung Cancer
Wei Zhou 32
Large-scale testing (Phase 3)Looking for participantsNCT05613478
What this trial is testing

Camrelizumab Combined With Apatinib Mesylate and TACE in the Perioperative Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaImmunotherapyPreoperative
The First Affiliated Hospital with Nanjing Medical University 130
Not applicableUnknownNCT04507750
What this trial is testing

Camrelizumab Combined With Apatinib in the Treatment of Epithelial Ovarian Cancer

Who this might be right for
Immune Checkpoint Inhibition
Qianfoshan Hospital 40
Testing effectiveness (Phase 2)UnknownNCT04411706
What this trial is testing

Sintilimab Combined With Apatinib and Capecitabine in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Xin-Hua Xu 46
Testing effectiveness (Phase 2)Study completedNCT03463876
What this trial is testing

A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib in Patients With Advanced HCC(RESCUE)

Who this might be right for
Hepatocellular Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 190
Testing effectiveness (Phase 2)UnknownNCT04826406
What this trial is testing

Camrelizumab Combined Apatinib in Hepatocellular Carcinoma Previously Treated With Immune Checkpoint Inhibitors (ICIs).

Who this might be right for
Hepatocellular CarcinomaImmune Checkpoint Inhibitors
Hunan Cancer Hospital 40
Testing effectiveness (Phase 2)UnknownNCT03132025
What this trial is testing

Study of Apatinib and Capecitabine Combination to Maintain Treating Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Yanqiao Zhang 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07587034
What this trial is testing

HAIC-TACE Plus Apatinib and Camrelizumab for Liver Cancer

Who this might be right for
Liver Cancer
Shanghai Zhongshan Hospital 315
Large-scale testing (Phase 3)Looking for participantsNCT05699655
What this trial is testing

Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 Vs Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer

Who this might be right for
Immunotherapy Gastrict Cancer
Fujian Cancer Hospital 130
Large-scale testing (Phase 3)Looking for participantsNCT06438627
What this trial is testing

Efficacy and Safety of TPC+Apatinib+Camrelizumab vs GP+ Camrelizumab for High-Risk Nasopharyngeal Carcinoma: A Phase 3 Trial

Who this might be right for
Nasopharyngeal Carcinoma
XIANG YANQUN 164
Testing effectiveness (Phase 2)UnknownNCT03788174
What this trial is testing

Apatinib Combined With POF for Second-line Treatment of Gastric Adenocarcinoma

Who this might be right for
Gastric Adenocarcinoma
Fujian Cancer Hospital 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT04666090
What this trial is testing

Carrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant Therapy
Second Affiliated Hospital, Zhejiang University, School of Medicine 42
Testing effectiveness (Phase 2)UnknownNCT05597527
What this trial is testing

Fluzopari Combined With Apatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer

Who this might be right for
Ovarian Cancer
Fujian Cancer Hospital 35
Large-scale testing (Phase 3)Active Not RecruitingNCT07371910
What this trial is testing

Fluorizoparib Plus Apatinib Versus Chemotherapy in HRD-positive, HER2-negative Advanced Breast Cancer

Who this might be right for
Metastatic Breast CancerHRD-Positive/HER2-Negative Advanced Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 200
Testing effectiveness (Phase 2)Study completedNCT03535961
What this trial is testing

Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer

Who this might be right for
Breast Cancer
Chinese Academy of Medical Sciences 32
Testing effectiveness (Phase 2)WithdrawnNCT03190239
What this trial is testing

Efficacy and Safety of Maintenance Apatinib Combined With Pemetrexed in Advanced Non-squamous Non-small Cell Lung Cancer Patients

Who this might be right for
Advanced Non-squamous Non-small-cell Lung Cancer
Xinqiao Hospital of Chongqing
Not applicableUnknownNCT04559607
What this trial is testing

TACE Combined With Camrelizumab and Apatinib in Intermediate and Advanced Hepatocelluar Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 188
Next Page